Literature DB >> 1537618

Nucleoside diphosphate kinase/NM23 expression in breast cancer: lack of correlation with lymph-node metastasis.

X Sastre-Garau1, M L Lacombe, M Jouve, M Véron, H Magdelénat.   

Abstract

The product of the nm23-H1 gene, reported to be a metastatic suppressor gene, was recently identified as the nucleoside diphosphate (NDP) kinase A, and was found to be overexpressed in several types of malignant tumors as compared with normal tissues. In order to determine whether NDP-kinase expression serves as a marker for metastatic potential and whether hyperproliferation of neoplastic cells would correlate with expression, we analyzed NDP-kinase levels and activity by immunohistochemical staining and by an enzymatic assay in 13 benign and 98 malignant breast-tissue specimens. Our results confirm that NDP-kinase expression increases in malignant cells of breast carcinomas, but cannot be considered as a biological marker of metastatic dissemination. No correlation was found between NDP-kinase activity and S phase, taken as an index of cell proliferation. Moreover, no correlation was observed between NDP-kinase activity and tumor size, histoprognostic index, estrogen receptors or progesterone receptors. The mechanism of over-expression of NDP in malignant cells and its role in tumor progression remain to be determined.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1537618     DOI: 10.1002/ijc.2910500406

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  29 in total

1.  Expression of nm23-H1 in colorectal cancer: no association with metastases, histological stage, or survival.

Authors:  Y Tabuchi; T Nakamura; T Kuniyasu; M Ohno; S Nakae
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

2.  Biological indices in the assessment of breast cancer.

Authors:  A S Leong; A K Lee
Journal:  Clin Mol Pathol       Date:  1995-10

3.  Mutational analysis of NM23-H2/NDP kinase identifies the structural domains critical to recognition of a c-myc regulatory element.

Authors:  E H Postel; V H Weiss; J Beneken; A Kirtane
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

4.  Evaluation of the prognostic significance of nm23/NDP kinase and cathepsin D in anal carcinomas. An immunohistochemical study.

Authors:  R Holm; G Tanum
Journal:  Virchows Arch       Date:  1996-05       Impact factor: 4.064

5.  Immunohistochemical detection of nm23/NDP kinase and cathepsin D in medullary carcinomas of the thyroid gland.

Authors:  R Holm; J Høie; O Kaalhus; J M Nesland
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

6.  A human NDP-kinase B specifically binds single-stranded poly-pyrimidine sequences.

Authors:  M Hildebrandt; M L Lacombe; S Mesnildrey; M Véron
Journal:  Nucleic Acids Res       Date:  1995-10-11       Impact factor: 16.971

7.  NM23 protein in neoplastic and nonneoplastic thyroid tissues.

Authors:  P Bertheau; A De La Rosa; P S Steeg; M J Merino
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

8.  Immunohistochemical analysis of nm23 protein expression in malignant bone tumors.

Authors:  Y Oda; H Walter; K Radig; I Röse; W Neumann; A Roessner
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

9.  Expression of nm23-H1 gene product in thyroid, ovary, and breast cancers.

Authors:  T Okubo; S Inokuma; S Takeda; S Itoyama; K Kinoshita; I Sugawara
Journal:  Cell Biophys       Date:  1995-06

Review 10.  Nm23 and breast cancer metastasis.

Authors:  P S Steeg; A de la Rosa; U Flatow; N J MacDonald; M Benedict; A Leone
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.